Search results
Ionis, Biogen Down on Ending Development of ALS Drug - Biogen (NASDAQ:BIIB), Heron Therapeutics...
Benzinga· 6 days agoShares of Ionis Pharmaceuticals (NASDAQ: IONS) and Biogen (NASDAQ: BIIB) lost at least 2% in market...
Ionis (IONS), Biogen Down on Ending Development of ALS Drug
Zacks· 6 days agoIonis (IONS) and Biogen (BIIB) stop developing their experimental ALS drug after a phase I/II study failed to show improvement in patients.
Morning Brew: Nvidia's AI Impact and Biogen's Acquisition Lead t
Guru Focus· 1 day agoS&P futures vs fair value: -9.00. Nasdaq futures vs fair value: -3.00.The S&P 500 futures are down...
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
InvestorPlace via Yahoo Finance· 6 days agoWith innovation, millions of retiring baby boomers, demand for better care, patent cliffs,...
Wall Street Favorites: 3 Biotech Stocks with Strong Buy Ratings for May 2024
InvestorPlace· 6 days agoWith innovation, millions of retiring baby boomers, demand for better care, patent cliffs,...
Parnassus Value Equity Fund's 1st-Quarter Commentary: A Recap
Guru Focus· 6 days agoThe Fund (Investor Shares) returned 10.17% for the quarter, outperforming the Russell 1000 Value Index's 8.99%. The outperformance was largely driven by stock selection in ...